Published: Jun 2nd, 2015
Members from The University of Florida Diabetes Institute recently presented their research findings at the ADA’s 75th Scientific Sessions Meeting in Boston. More than 40 UF physicians, researchers, graduate students, and faculty took part in this year’s programming. Read more.
Published: Dec 23rd, 2014
Benjamin Keselowsky, Ph.D. has received a new NIH R01 grant for “Biomaterial Delivery System for Type 1 Diabetes Vaccine”. Funded by the National Institute of Diabetes and Digestive and Kidney Diseases in collaboration with UF Diabetes Institute Director, Mark Atkinson, Ph.D., and Clive Wasserfall, this, $1.5M grant will fund the investigation of biodegradable microparticle/hydrogel formulations delivering immuno-modulatory factors to targeted immune cell types for the prevention and reversal of T1D.
Published: Jun 21st, 2014
UF and UF Health faculty, postdoctoral fellows, and graduate students submitted a record number of original research presentations for the American Diabetes Association’s 74th Scientific Sessions held June 13-17, 2014 at the Moscone Center in San Francisco, California. This year’s submissions represent one of the largest showcases of research emanating from UF.
Published: May 29th, 2014
Learn about the latest drug-delivery system developed by University of Florida researches that holds the promise for ways to treat and ultimately prevent persons from developing Type 1 Diabetes. The joint effort is bringing research closer to a cure.
Published: May 20th, 2010
Visit the JDRF nPOD website The Network for Pancreatic Organ Donors with Diabetes (nPOD) program, supported by JDRF at the University of Florida, is the world’s largest open research consortium dedicated to […]
Published: May 1st, 2009
Study Name: Immune Function During Various Stages of Insulin Dependent Diabetes Principal Investigator: Mark Atkinson, Ph.D. Study Coordinator: Clive Wasserfall, M.S. | Jamie Thomas Phone: 352-294-5760 What is the Immune Function […]